Paragard T 380a Intrauterine Device
NDC Package 59365-5129-1
Package Information
Paragard T 380a (copper) intrauterine devices is paragard is indicated for prevention of pregnancy in females of reproductive potential for up to 10 years. This formulation utilizes a intrauterine device delivery system. Marketed by Coopersurgical, Inc., this product is identified by NDC 59365-5129 and is authorized under FDA application NDA018680.
Identification & Billing
- RxCUI: 2267305 - copper 313.4 MG Drug Implant
- RxCUI: 2267305 - copper 313 MG Drug Implant
- RxCUI: 2267310 - PARAGARD 313.4 MG Drug Implant
- RxCUI: 2267310 - copper 313 MG Drug Implant [ParaGard]
- RxCUI: 2267310 - ParaGard 313 MG Drug Implant
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59365 - Coopersurgical, Inc.
- 59365-5129 - Paragard T 380a
- 59365-5129-1 - 1 POUCH in 1 CARTON / 1 INTRAUTERINE DEVICE in 1 POUCH
- 59365-5129 - Paragard T 380a
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59365-5129-1 identifies a specific commercial package of 1 pouch in 1 carton / 1 intrauterine device in 1 pouch of Paragard T 380a, a human prescription drug labeled by Coopersurgical, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This intrauterine device is formulated for intrauterine use and contains copper as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Coopersurgical, Inc. on August 15, 2024. The current certification is valid through December 31, 2026.
How is this Coopersurgical, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59365512901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.